Brentuximab vedotin with dacarbazine or nivolumab as frontline cHL therapy for older patients ineligible for chemotherapy
| Autor: | Friedberg, Jonathan W., Bordoni, Rodolfo, Patel-Donnelly, Dipti, Larson, Timothy, Goldschmidt, Jerome, Boccia, Ralph, Cline, Vivian J. M., Mamidipalli, Adrija, Liu, Jingmin, Akyol, Alev, Yasenchak, Christopher A. |
|---|---|
| Zdroj: | In Blood 29 February 2024 143(9):786-795 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|